PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

102 hedge funds and large institutions have $245M invested in Pacific Biosciences in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+8
Holders Change %
+8.51%
% of All Funds
2.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
42
Reduced
26
Closed
7
Calls
$229K
Puts
$335K
Net Calls
-$106K
Net Calls Change
-$51K

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$31.1M
2
Millennium Management
2
Millennium Management
New York
$19.8M
3
EAM
3
EverPoint Asset Management
Connecticut
$5.18M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.78M
5
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$3.51M

Top Sellers

1
DM
1
Deerfield Management
New York
$8.56M
2
NI
2
Numeric Investors
Massachusetts
$1.35M
3
BA
3
BlackRock Advisors
Delaware
$13.4M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$0
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Manulife (Manufacturers Life Insurance)
101
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$250 +$23 +3,975 +10%
Dimensional Fund Advisors
102
Dimensional Fund Advisors
Texas
– -$1.96M -335,413 Closed
JPMorgan Chase & Co
103
JPMorgan Chase & Co
New York
– -$819K -140,355 Closed
Jacobs Levy Equity Management
104
Jacobs Levy Equity Management
New Jersey
– -$163K -27,900 Closed
TC
105
TFS Capital
Pennsylvania
– -$152K -26,034 Closed
QI
106
QS Investors
New York
– -$16K -2,707 Closed
Creative Planning
107
Creative Planning
Kansas
– -$8K -1,310 Closed
Federated Hermes
108
Federated Hermes
Pennsylvania
– -$5K -838 Closed
1 2 3 4
5